Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Create Alert
Watchlist
Venmax Drugs & Pharmaceuticals
₹24.60
-0.35 (1.40%) 1D
Performance
Open
24.70Prev. Close
24.95Volume
713Total traded value
0.00 CrUpper Circuit
26.19Lower Circuit
23.71Fundamentals
| Market Cap | ₹20Cr |
| ROE | 4.02% |
| P/E Ratio(TTM) | 58.02 |
| EPS(TTM) | 0.43 |
| P/B Ratio | 2.33 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.71 |
| Book Value | 10.71 |
| Debt to Equity | 0.36 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Venmax Drugs
Venmax Drugs & Pharmaceuticals is in the business of making pharmaceutical products, drug intermediaries, and Active Pharmaceutical Ingredients (APIs). The company's management is looking into alternative business proposals to resume operations in the future. In the last financial year, the company incurred a loss of Rs. 6.45 Lakhs due to the absence of business activity.;
| Parent Organisation | Venmax Drugs & Pharmaceuticals Limited |
| BSE Symbol | 531015 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 68.31 | ||
| Neuland Laboratories | NA (0.00%) | 81.15 | ||
| Jubilant Pharmova | NA (0.00%) | 36.09 | ||
| Acutaas Chemicals | NA (0.00%) | 61.77 |
2025
12
Nov
Quarterly Result
Release date
23
Jul
Quarterly Result
Release date
9
May
Annual Result
Release date
8
Feb
Quarterly Result
Release date
2024
11
Nov
Quarterly Result
Release date
12
Aug
Quarterly Result
Release date
14
May
Annual Result
Release date
Events calendar
View upcoming events in other stocks